Logos Global Management Reiterates Urgent Strategic Reset with $700M Capital Return and Cost Cuts at Arvinas, Inc. (ARVN)
Market Cap: $537 million | Arvinas, Inc., a clinical-stage biotechnology company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins.
On June 10, 2025, Logos Global Management (6.4%) urged the board to pursue a strategic reset—recommending a special distribution to shareholders, halting early-stage pipeline investments, adopting a leaner cost structure, and avoiding independent development of the lead asset without a strategic partner. Source
On August 22, 2025, Logos Global Management (8.6%) stated that on August 7, 2025, they reiterated the need for an urgent reset, recommending a $700 million capital return, major cost cuts, a 1-for-5 reverse split, and disciplined capital allocation to restore confidence and preserve value, while leaving open the possibility of pursuing other actions under Schedule 13D. Source
Member discussion